Riskpilot← Back to searchSign inGet full accessTKO Medicals Oy
OYDissolvedY-tunnus 3282092-7Kukankaari 3Medical specialists activities · NACE 8622Est. 20221 employees
Revenue 2025
EUR 183K
+140% vs 2024
EBITDA margin
74.4%
+182% vs 2024
Equity ratio
76.0%
Financial strength
Net profit 2025
EUR 105K
+216% vs 2024
| Revenue | EUR 183K | +140% |
| EBITDA | EUR 136K | +182% |
| Net profit | EUR 105K | +216% |
| Total assets | EUR 265K | +26% |
| Equity | EUR 201K | +93% |
| Employees | 1 | — |
Legal name
TKO Medicals Oy
Y-tunnus number
3282092-7
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
20. huhtikuuta 2022
Share capital
EUR 0
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Toimialana on lääkäripalvelujen tarjoaminen potilaille. Lääkäripalveluasemaliiketoiminta, yksityis- ja erikoislääkäripalvelut, terveyskeskus- ja vastaavat yleislääkäripalvelut, sekä konsultointi ja koulutus. Tämän lisäksi yhtiö voi omistaa, hallita, saneerata, ostaa, myydä ja vuokrata kiinteistöjä, osakehuoneistoja, osakkeita, sekä harjoittaa arvopaperikauppaa ja myös muuta sijoitustoimintaa. Kaikki muu laillinen liiketoiminta.
Address
Kukankaari 3
Email
tobias.olenius@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 143 | 76 | 183 |
| Staff expenses | −14 | −2 | −4 |
| EBITDA | 101 | 48 | 136 |
| Depreciation & amort. | −1 | −1 | −1 |
| EBIT | 100 | 47 | 135 |
| Net financials | −4 | −6 | −4 |
| Profit before tax | 97 | 42 | 132 |
| Tax | 19 | 8 | 26 |
| Net profit | 78 | 33 | 105 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 192 | 210 | 265 |
| Equity | 78 | 105 | 201 |
| Long-term debt | 83 | 73 | 39 |
| Short-term debt | 31 | 32 | 25 |
| Total debt | 114 | 105 | 64 |
EBITDA margin
74.4%
This company
15.8%
Market median
+371% vs market
20232025
Equity ratio
76.0%
This company
38.2%
Market median
+99% vs market
20232025
Return on equity
52.2%
This company
18.4%
Market median
+184% vs market
20232025
Net profit margin
57.6%
This company
8.1%
Market median
+611% vs market
20232025
Asset turnover
0.69×
This company
1.12×
Market median
-38% vs market
20232025
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
20232025
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TK Chief Executive Officer | Chief Executive Officer | 2022 |
CH Deputy Member | Deputy Member | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TKO Medicals Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tobias Kasper Olenius | Chief Executive Officer | 0 companies |
| Christian Hemming Olenius | Deputy Member | 0 companies |